Ces radiol. 2014, 68(1):69-73
Evaluation of T2 lesions at baseline brain MRI as a prognostic marker in prediction the conversion of CIS to CDMSOriginal article
- 1 ProMagnet s.r.o, pracovisko magnetickej rezonancie FNsP J. A. Reimana, Prešov
- 2 Klinika neurológie FZO Prešovskej univerzity a FNsP J. A. Reimana, Prešov
- 3 Geriatrické centrum sv. Lukáša, Košice
Aim: Clinically isolated syndrome (Clinically Isolated Syndrome, CIS) can be the first manifestation of multiple sclerosis (MS). As a potential prognostic marker for "Identify" CIS patients with high risk of conversion to clinically Definited MS (CDMS, Poser 1983) is considered the number of T2 hypersignal brain lesions in first MR examination of the CIS patient. The aim of the study was to verify the importance of T2 hypersignal brain lesions in the first MR examination of the patient at the time of the CIS as a potential prognostic marker for the development of SM in own group of patients.
Method: retrospective evaluation of MR findings of 76 patients at the time of the CIS for the period from 06/2005 to 12/2012. All CIS patients had clinical and radiographic follow-up for at least two years. Determined parameters: gender, age of the patient at the time of the CIS, the CIS clinical picture, the number of T2 lesions on initial MRI examination.
Results: The study comprised 76 patients with a mean age at the time of CIS 34.12 ± 8.55 years. Women dominated in the set (60). To CDMS passed 31 patients (46.27%). Logrank test (p = 0.0046) comparing survival curves, the method of Cox proportional hazards model, as well as multivariate regression analysis (p = 0.0538) confirmed in our study that a higher number of T2 lesions at baseline MRI, poses a high risk of early transition CIS to CDMS.
Conclucion: Higher number of hypersignal T2 lesions on initial MR examination after CIS in our group meant a higher risk of conversion CIS to CDMS. As another possible risk factor predictive of conversion of CIS to CDMS was in accordance with literature multifocal nature of the CIS. Without statistical significance at the endpoints was the age and gender of patients at the time of the CIS.
Keywords: clinically isolated syndrome, clinically definite MS, magnetic resonance imaging, multiple sclerosis, prognostic marker
Accepted: February 15, 2014; Published: March 1, 2014 Show citation
References
- Horáková D. Klinický izolovaný syndrom a prognostické markery u roztroušené sklerózy. Proč léčit včas? Neurologie pro praxi 2008; 9: 215-217.
- Tintoré M, Rovira A, Rio J, et al. Baseline MRI predicts future attacks and disability in clinically isolated syndromes. Neurology 2006; 67(6): 968-972.
Go to original source...
Go to PubMed...
- Fisniku LK, Brex PA, Altmann DR, et al. Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain 2008; 131: 808-817.
Go to original source...
Go to PubMed...
- Jacobs LD, Beck RW, Simon JH, et al. Intramuscular interferon β-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. N Engl J Med 2000; 343: 898-904.
Go to original source...
Go to PubMed...
- Comi G, Filippi M, Barkhof F, et al. 2001. Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study. Lancet 2001; 357: 1576-1582.
Go to original source...
Go to PubMed...
- Kappos L, Polman CH, Freedman MS, et al. Treatment with interferon β-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes. Neurology 2006; 67: 1242-1249.
Go to original source...
Go to PubMed...
- Comi G, Martinelli V, Rodegher M, et al. Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial. Lancet 2009; 374: 1503-1511.
Go to original source...
Go to PubMed...
- Tantsis EM, Prelog K, Brilot F, et al. Risk of multiple sclerosis after a first demyelinating syndrome in an Australian Paediatric cohort: clinical, radiological features and application of the McDonald 2010 MRI criteria. Mult Scler [online] 2013 [citované 2013-07-25]. Dostupné na: http://msj.sagepub.com/content/early/2013/04/11/1352458513484377
- Bainbridge J. Clinically isolated syndrome: why to treat. Advanced Studies in Pharmacy 2010; 7(3): 63-67.
- Tintoré M, Rovira A, Rio J, et al. Is optic neuritis more benign tahn other first attacks in multiple sclerosis? In Ann Neurol 2005; 57: 210-215.
Go to original source...
Go to PubMed...
- Giorgio A, Battaglini M, Rocca M, et al. Relevance of Brain Lesion Distribution and Frequency for Short-Term Conversion of Patients with Clinically Isolated Syndrome to Multiple Sclerosis. Meeting Abstracts. In Neurology [online] 2012; 78 [cit. 2013-08-13]. Dostupné na: http://registration.akm.ch/einsicht.php?XNABSTRACT_ID=138308&XNSPRACHE_ID=2&XNKONGRESS_ID=150&XNMASKEN_ID=900>. ISSN 0028-3878
Go to original source...
- Dobson R, Ramagopalan S, Giovannoni G. The effect of gender in clinically isolated syndrome (CIS): a meta-analysis. In Mult Scler 2012; 18(5): 600-604.
Go to original source...
Go to PubMed...
- Vaněčková M, Seidl Z, Krásenský J, et al. Naše zkušenosti s MR monitorováním pacientů s roztroušenou sklerózou v klinické praxi. Cesk Slov Neurol N 2010; 73/106: 716-720.
- Brex PA, Ciccarelli O, O'Riordan JI, et al. A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 2002; 346: 158-164.
Go to original source...
Go to PubMed...
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.